Optic Neuritis
📧 Sign up to get email alerts when something new happens for Optic Neuritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Gypenosides Treatment for Optic Neuritis [Phase 2]
Phase 2 trial of Gypenosides for optic neuritis was terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis
A completed clinical trial from University Hospital, Lille investigates the relationship between optic nerve MRI findings and retinal axonal…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: OCS-05 in Patients With Optic Neuritis [Phase 2]
OCS-05 Phase 2 trial in optic neuritis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Building Research With Artificial Intelligence in Neuro-Ophthalmology
The clinical trial update indicates completion of a study examining artificial intelligence and machine learning applications in neuro-ophth…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis
A completed clinical study evaluating optical coherence tomography in optic neuritis not related to multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Edaravone in the Treatment of Optic Neuritis [NA]
A clinical trial is investigating edaravone for optic neuritis and is currently recruiting at the First Affiliated Hospital of Guangxi Medic…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: High-Dose Vitamin D Induction in Optic Neuritis [Phase 2]
Phase 2 trial of high-dose vitamin D for optic neuritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Visual Reconstitution Therapy After Optic Neuritis [Phase 2]
Phase 2 trial update on visual reconstitution therapy for optic neuritis, with conditions including optic neuritis and multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating retrobulbar methylprednisolone as an adjunctive treatment for optic neuritis. Current status is unknow…
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Ampyra for Optic Neuritis in Multiple Sclerosis [Phase 2, Phase 3]
Phase 2/Phase 3 trial update for Ampyra in optic neuritis associated with multiple sclerosis; results have been posted following completion.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating erythropoietin for optic neuritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Long-Term Assessment of Remyelinating Therapy [Phase 2]
Phase 2 clinical trial assessing a remyelinating therapy for acute optic neuritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Effect of Phenytoin on the Ganglion Cell Layer in Patients With Optic Neuritis [Phase 2]
Phase 2 clinical trial evaluating the effect of phenytoin on the ganglion cell layer in patients with optic neuritis has completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Amiloride Clinical Trial In Optic Neuritis [Phase 2]
A Phase 2 trial of amiloride for optic neuritis has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis [Phase 4]
Long-term Phase 4 study investigating Avonex therapy after a first attack in multiple sclerosis patients; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis [EARLY_Phase 1]
This clinical trial update reports the completion of an early-phase Phase 1 study evaluating ACTHAR's functional and neuroprotective potenti…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Pupillometry Dynamic Measures in Patients Without Ocular or Neurological Disease
A completed clinical trial update examining dynamic pupillometry measures in participants without ocular or neurological disease, with optic…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis [Phase 3]
Phase 3 study evaluating MD1003 for chronic visual loss related to optic neuritis in multiple sclerosis; current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes [Phase 1]
This Phase 1 study reports pharmacokinetics, safety and tolerability of single doses of Opicinumab (BIIB033) produced by two manufacturing p…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: BIIB033 In Acute Optic Neuritis (AON) [Phase 2]
Biogen's BIIB033 Phase 2 trial in acute optic neuritis has completed and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial update evaluating Nerispirdine's impact on visual function in patients with multiple sclerosis, including optic neu…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Atacicept in Subjects With Optic Neuritis [Phase 2]
This is a Phase 2 trial update for atacicept in optic neuritis; the study was terminated and results were posted on 2016-02-17.
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Neuroprotection With Phenytoin in Optic Neuritis [Phase 2]
Phase 2 trial assessing phenytoin for neuroprotection in optic neuritis (with participants also having multiple sclerosis) has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Optic Neuritis Recovery After Oral or IV Corticosteroids [Phase 2, Phase 3]
This update reports the completion of a Phase 2/3 trial examining recovery from optic neuritis after oral or intravenous corticosteroid ther…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater [Phase 3]
Phase 3 study evaluating eye function in patients taking Linezolid for six weeks or longer was terminated, with results posted in 2015.